PirainoB.Peritonitis as a complication of peritoneal dialysis.J Am Soc Nephrol1998; 9: 1956–64.
2.
KeaneW.F., EverettE.D., GolperT.A., GokalR., HalstensonC., KawaguchiY.Peritoneal dialysis-related peritonitis treatment recommendations: 1993 update. The Ad Hoc Committee on Peritonitis Management. International Society for Peritoneal Dialysis.Perit Dial Int1993; 13: 14–28.
BoyceN.W., WoodC., ThomsonN.M., KerrP., AtkinsR.C.Intraperitoneal (IP) vancomycin for CAPD peritonitis — a prospective, randomized comparison of intermittent v continuous therapy.Am J Kidney Dis1988; 12: 304–6.
9.
BailieG.R., MortonR., GanguliL., KeaneyM., WaldekS.Intravenous or intraperitoneal vancomycin for the treatment of continuous ambulatory peritoneal dialysis associated gram-positive peritonitis?Nephron1987; 46: 316–18.
10.
MulhernJ.G., BradenG.L., O'SheaM.H., MaddenR.L., LipkowitzG.S., GermainM.J.Trough serum vancomycin levels predict the relapse of gram-positive peritonitis in peritoneal dialysis patients.Am J Kidney Dis1995; 25: 611–15.
11.
LowC.L., GopalakrishnaK., LyeW.C.Pharmacokinetics of once daily intraperitoneal cefazolin in continuous ambulatory peritoneal dialysis patients.J Am Soc Nephrol2000; 11: 1117–21.
12.
ManleyH.J., BailieG.R., AsherR.D., EiseleG., FryeR.F.Pharmacokinetics of intermittent intraperitoneal cefazolin in continuous ambulatory peritoneal dialysis patients.Perit Dial Int1999; 19: 65–70.
13.
KhairullahQ., ProvenzanoR., TayebJ., AhmadA., BalakrishnanR., MorrisonL.Comparison of vancomycin verses cefazolin as initial therapy for peritonitis in peritoneal dialysis patients.Perit Dial Int2002; 22: 339–44.
14.
WeberJ., StaerzE., MettangT., MachleidtC., KuhlmannU.Treatment of peritonitis in continuous ambulatory peritoneal dialysis (CAPD) with intraperitoneal cefazolin and gentamicin.Perit Dial Int1989; 9: 191–5.
15.
GoldbergL., ClemengerM., AzadianB., BrownE.A.Initial treatment of peritoneal dialysis peritonitis without vancomycin with a once-daily cefazolin-based regimen.Am J Kidney Dis2001; 37: 49–55.
16.
LaiM.N., KaoM.T., ChenC.C., CheungS.Y., ChungK.W.Intraperitoneal once-daily dose of cefazolin and gentamicin for treating CAPD peritonitis.Perit Dial Int1997; 17: 87–9.
17.
FieldingR.E., ClemengerM., GoldbergL., BrownE.A.Treatment and outcome of peritonitis in automated peritoneal dialysis, using a once-daily cefazolin-based regimen.Perit Dial Int2002; 22: 345–9.
WaiteN.M., JohnsonM.D., WebsterN.R., FongI.W.Poor response to oral ciprofloxacin in the treatment of peritonitis in patients on intermittent peritoneal dialysis.Perit Dial Int1993; 13: 50–4.
20.
ChengI.K., ChanC.Y., WongW.T., ChengS.W., RichieC.W., CheungW.C.A randomized prospective comparison of oral versus intraperitoneal ciprofloxacin as the primary treatment of peritonitis complicating continuous ambulatory peritoneal dialysis.Perit Dial Int2001; 21: 199–200.
21.
FlemingL.W., PhillipsG., StewartW.K., ScottA.C.Oral ciprofloxacin in the treatment of peritonitis in patients on continuous ambulatory peritoneal dialysis.J Antimicrob Chemother1990; 25: 441–8.
22.
KaysM.B., OverholserB.R., MuellerB.A., MoeS.M., SowinskiK.M.Effect of sevelamer hydrochloride and calcium acetate on the oral bioavailability of ciprofloxacin.Am J Kidney Dis2003; 42: 1253–9.
23.
LyeW.C., van der StraatenJ.C., LeongS.O., SivaramanP., TanS.H., TanC.C.Once daily intraperitoneal gentamicin is effective therapy for gram-negative CAPD peritonitis.Perit Dial Int1999; 19: 357–60.
24.
VasS.I.Single daily dose of aminoglycosides in the treatment of continuous ambulatory peritoneal dialysis peritonitis.Perit Dial Int1993; 13(Suppl 2): S355–6.
25.
BailieG.R., HaqqieS.S., EiseleG., GormanT., LowC.L.Effectiveness of once-weekly vancomycin and once-daily gentamicin, intraperitoneally, for CAPD peritonitis.Perit Dial Int1995; 15: 269–71.
SheminD., MaazD., St PierreD., KahnS.I., ChazanJ.A.Effect of aminoglycoside use on residual renal function in peritoneal dialysis patients.Am J Kidney Dis1999; 34: 14–20.
28.
BakerR.J., SeniorH., ClemengerM., BrownE.A.Empirical aminoglycosides for peritonitis do not affect residual renal function.Am J Kidney Dis2003; 41: 670–5.
